|
|
|
|
|
|
|
|
|
14.10.26 - 07:48
|
Lonza setzt sich ambitionierte Finanzziele (Moneycab)
|
|
|
Lonza will nach Abschluss der Transformation zu einem fokussierten Pharmazulieferer noch profitabler werden. Die Basler haben am Mittwoch im Vorfeld eines Investorentages ihre neuen finanziellen Ziele vorgestellt....
|
|
|
|
|
|
|
14.10.26 - 06:33
|
Ad-hoc News: Lonza Group AG (EQS)
|
|
|
Lonza Upgrades Organic Growth Model and Mid-term Financial Ambitions at Capital Markets Day; Q3 2026 In Line with Expectations...
|
|
|
14.10.26 - 06:12
|
WOCHENVORSCHAU: Termine bis 27. Oktober 2026 (DPA-AFX)
|
|
|
FRANKFURT (dpa-AFX) - Wirtschafts- und Finanztermine bis Dienstag, den 27. Oktober^---------------------------------------------------------------------------------------MITTWOCH, DEN 14. OKTOBERTERMINE UNTERNEHMEN06:30 CHE: Lonza, Q3-Umsatz07:00 ......
|
|
|
14.10.26 - 06:12
|
TAGESVORSCHAU: Termine am 14. Oktober 2026 (DPA-AFX)
|
|
|
FRANKFURT (dpa-AFX) - Wirtschafts- und Finanztermine am Mittwoch, den 14. Oktober^TERMINE UNTERNEHMEN06:30 CHE: Lonza, Q3-Umsatz07:00 NLD: ASML, Q3-Zahlen07:00 NLD: ABN Amro, Pre-Close Note Q3/26510:00 NLD: Redcare Pharmacy, ......
|
|
|
13.10.26 - 17:42
|
TAGESVORSCHAU: Termine am 14. Oktober 2026 (DPA-AFX)
|
|
|
FRANKFURT (dpa-AFX) - Wirtschafts- und Finanztermine am Mittwoch, den 14. Oktober^TERMINE UNTERNEHMEN06:30 CHE: Lonza, Q3-Umsatz07:00 NLD: ASML, Q3-Zahlen07:00 NLD: ABN Amro, Pre-Close Note Q3/26510:00 NLD: Redcare Pharmacy, ......
|
|
|
13.10.26 - 17:42
|
WOCHENVORSCHAU: Termine bis 27. Oktober 2026 (DPA-AFX)
|
|
|
FRANKFURT (dpa-AFX) - Wirtschafts- und Finanztermine bis Dienstag, den 27. Oktober^---------------------------------------------------------------------------------------MITTWOCH, DEN 14. OKTOBERTERMINE UNTERNEHMEN06:30 CHE: Lonza, Q3-Umsatz07:00 ......
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
30.09.26 - 18:09
|
Argonaut Manufacturing Services Appoints J.D. Mowery to Board of Directors (Business Wire)
|
|
|
CARLSBAD, Calif.--(BUSINESS WIRE)--Argonaut Manufacturing Services (Argonaut), a U.S.-based contract development and manufacturing organization (CDMO) providing sterile fill-finish services for injectable biologics and pharmaceuticals, today announced the appointment of J.D. Mowery to its Board of Directors.Mowery brings more than two decades of leadership experience across global biopharmaceutical manufacturing, CDMO operations, and biotechnology organizations. Most recently, he served as President of the global CDMO division at Bora Pharmaceuticals, where he led strategy, commercial growth, and operations across a multi-site manufacturing network in North America and Asia. Previously, he served as President and CEO of KBI Biopharma and as an Officer of its parent company, JSR Corporation.His career also includes senior operational leadership positions at AGC Biologics, Juno Therapeutics, and Lonza, spanning biologics, cell and gene therapies, and aseptic manufacturing. Across these roles, he has led org...
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
